We followed total prostate and prostatic tumor volumes in patients who received combination endocrine therapy with the antiandrogen flutamide and the LHRH agonist [D-Trp6,des-Gly-NH2(10)]LHRH ethylamide. Twenty-three men with proved prostatic adenocarcinoma (Stages B1 to D2) were subjected to a transrectal ultrasound (TRUS) study before and after a three-month period of combination antihormonal therapy. A total prostatic volume reduction ranging from 17 percent to 70 percent (median 47%, p less than 0.0001) was observed. An even greater effect was observed on tumor volume which was reduced by 20 percent to 91 percent (median 81%, p less than 0.01). After treatment, the original suspicious zone became nonvisible in 4 cases. The TRUS measurements were confirmed by direct examination of the radical prostatectomy specimen in 7 cases. TRUS is thus a precise, sensitive, and valid method for evaluating the effect of combined antihormonal therapy on normal and tumoral prostatic tissues. These data indicate that combination therapy induces a rapid and marked reduction in glandular and tumoral prostatic volume which could well improve the success of radical prostatectomy and increase the changes of cure of localized prostatic cancer.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0090-4295(92)90301-cDOI Listing

Publication Analysis

Top Keywords

transrectal ultrasound
8
lhrh agonist
8
antihormonal therapy
8
prostatic volume
8
percent percent
8
percent median
8
cases trus
8
radical prostatectomy
8
tumoral prostatic
8
prostatic
6

Similar Publications

Investigation and Treatment of Infertility in a Female Black Rhinoceros (Diceros bicornis).

Zoo Biol

January 2025

Taronga Conservation Society Australia, Taronga Institute of Science and Learning, Mosman New South Wales 2088, Taronga Western Plains Zoo, Dubbo, New South Wales, Australia.

A zoo-based, 11-year-old, uniparous southern black rhinoceros (Diceros bicornis minor) failed to conceive after weaning a calf. Behavioral observation and fecal progestagen monitoring confirmed irregular estrous cycles. Serial transrectal reproductive ultrasound examination revealed the cause to be recurrent anovulatory hemorrhagic follicles (AHFs).

View Article and Find Full Text PDF

Ultrasound radiomics model based on grayscale transrectal ultrasound-guided biopsy for diagnosing prostate cancer and predicting distant metastasis.

Int Urol Nephrol

January 2025

Department of Ultrasound, The First College of Clinical Medical Science, China Three Gorges University, Yichang Central People's Hospital, No. 2 Jiefang Road, Xiling District, Yichang, Hubei, China.

Objective: A prostate ultrasound (US) imaging omics model was established to assess its effectiveness in diagnosing prostate cancer (PCa), predicting Gleason score (GS), and determining the likelihood of distant metastasis.

Methods: US images of patients with prostate pathology confirmed by biopsy or surgery at our hospital were retrospectively analyzed. Regions of interest (ROI) segmentation, feature extraction, feature screening, and the construction and training of the radiomics model were performed.

View Article and Find Full Text PDF

Background: Prostate cancer (PCa) is the leading cause of cancer-related morbidity and mortality in men worldwide. An early and accurate diagnosis is crucial for effective treatment and prognosis. Traditional invasive procedures such as image-guided prostate biopsy often cause discomfort and complications, deterring some patients from undergoing these necessary tests.

View Article and Find Full Text PDF

Purpose: This study aimed to explore a combined transrectal ultrasound (TRUS) and radiomics model for predicting tumor regression grade (TRG) after neoadjuvant chemoradiotherapy (NCRT) in patients with locally advanced rectal cancer (LARC).

Methods: Among 190 patients with LARC, 53 belonged to GRG and 137 to PRG. Eight TRUS parameters were identified as statistically significant (P < 0.

View Article and Find Full Text PDF
Article Synopsis
  • Developed a 3-D acoustic radiation force impulse (ARFI) system for prostate imaging to identify cancerous regions and guide biopsies in one visit using a transrectal probe and 3-D visualization software.
  • The system was tested in a clinical trial comparing ARFI-guided targeted transperineal biopsies with other standard biopsy methods.
  • Results showed ARFI was less effective for lower-grade cancers but performed well for higher-grade cancers, suggesting it could enhance biopsy accuracy when combined with 2-D imaging techniques.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!